Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Washington University School of Medicine
Baptist Health South Florida
OHSU Knight Cancer Institute
Massachusetts General Hospital
St. Jude Children's Research Hospital
Cedars-Sinai Medical Center
Dana-Farber Cancer Institute
Medical College of Wisconsin
Memorial Sloan Kettering Cancer Center
UNICANCER
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
OHSU Knight Cancer Institute
St. Jude Children's Research Hospital
Rush University Medical Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Wake Forest University Health Sciences
University of South Florida
University of California, San Francisco
UNICANCER
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Ann & Robert H Lurie Children's Hospital of Chicago
Jonsson Comprehensive Cancer Center
Northwestern University
Northwestern University
Case Comprehensive Cancer Center
Children's Hospital of Philadelphia
University of California, San Francisco
University of Texas Southwestern Medical Center
Northwestern University
Northwestern University
The Cleveland Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Alliance for Clinical Trials in Oncology
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
University of California, San Francisco
Memorial Sloan Kettering Cancer Center
Burzynski Research Institute